Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity.
Cao Y, Li Y, Wang X, Liu S, Zhang Y, Liu G, Ye S, Zheng Y, Zhao J, Zhu X, Chen Y, Xu H, Feng D, Chen D, Chen L, Liu W, Zhou W, Zhang Z, Zhou P, Deng K, Ye L, Yu Y, Yao Z, Liu Q, Xu H, Zhou J. Cao Y, et al. Among authors: ye l, ye s. Immunity. 2023 Feb 14;56(2):320-335.e9. doi: 10.1016/j.immuni.2022.12.017. Epub 2023 Jan 23. Immunity. 2023. PMID: 36693372 Free article.
Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity.
Cao Y, Li Y, Wang X, Liu S, Zhang Y, Liu G, Ye S, Zheng Y, Zhao J, Zhu X, Chen Y, Xu H, Feng D, Chen D, Chen L, Liu W, Zhou W, Zhang Z, Zhou P, Deng K, Ye L, Yu Y, Yao Z, Liu Q, Xu H, Zhou J. Cao Y, et al. Among authors: ye l, ye s. Immunity. 2023 May 9;56(5):1148-1151. doi: 10.1016/j.immuni.2023.03.019. Immunity. 2023. PMID: 37163984 Free article. No abstract available.
Dopamine Receptor 1 Impedes ILC2-Mediated Antitumor Immunity.
Wang X, Chen X, Chen J, Liao C, Yang X, Zhou J, Liu S, Ye S, Zheng Y, Huang L, Zhao J, Ye L, Huang B, Cao Y. Wang X, et al. Among authors: ye l, ye s. J Immunol. 2023 Nov 1;211(9):1418-1425. doi: 10.4049/jimmunol.2300220. J Immunol. 2023. PMID: 37728417
Safety, tolerability, pharmacokinetics, and pharmacodynamics of TG103 injection in participants who are overweight or obese: a randomized, double-blind, placebo-controlled, multiple-dose phase 1b study.
Lin D, Xiao H, Yang K, Li J, Ye S, Liu Y, Jing S, Lin Y, Yang Y, Huang L, Yuan J, Li Z, Yang J, Gao H, Xie Y, Xu M, Yan L. Lin D, et al. Among authors: ye s. BMC Med. 2024 May 29;22(1):209. doi: 10.1186/s12916-024-03394-z. BMC Med. 2024. PMID: 38807146 Free PMC article. Clinical Trial.
6,145 results